Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
WELLS FARGO & COMPANY/MN | 02-09-2024 | 12-31-2023 | 18977 | 383,349,598,919 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
APOLLO SR FLOATING RATE FD I | COM | 3301 | $2,272,115 | 171,480 | 0.00 | 0.00 | -298,764 | -63.53 | 12-31-2023 |
AMPHASTAR PHARMACEUTICALS IN | COM | 3302 | $2,267,546 | 36,662 | 0.00 | 0.00 | 8,439 | 29.90 | 12-31-2023 |
CORE LABORATORIES INC | COM | 3303 | $2,263,618 | 128,178 | 0.00 | 0.00 | -46,428 | -26.59 | 12-31-2023 |
VERACYTE INC | COM | 3304 | $2,262,973 | 82,260 | 0.00 | 0.00 | -33,334 | -28.84 | 12-31-2023 |